These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28128734)

  • 1. MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified.
    Lin Y; Chen WM; Wang C; Chen XY
    Cancer Biomark; 2017; 18(4):339-347. PubMed ID: 28128734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
    Li M; Lü N; Liu HX; Chen DB; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Piccaluga PP; Fuligni F; Rossi M; Agostinelli C; Righi S; Sapienza MR; Motta G; Gazzola A; Mannu C; Sabattini E; Bacci F; Tabanelli V; Sacchetti CA; Barrese TZ; Etebari M; Melle F; Clò A; Gibellini D; Tripodo C; Inghirami G; Croce CM; Pileri SA
    Blood Cancer J; 2014 Nov; 4(11):259. PubMed ID: 25382608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
    Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
    Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.
    Valleron W; Ysebaert L; Berquet L; Fataccioli V; Quelen C; Martin A; Parrens M; Lamant L; de Leval L; Gisselbrecht C; Gaulard P; Brousset P
    Blood; 2012 Nov; 120(19):3997-4005. PubMed ID: 22990019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
    Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T-cell lymphoma gene expression profiles.
    Martinez-Delgado B
    Hematol Oncol; 2006 Sep; 24(3):113-9. PubMed ID: 16676369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
    Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
    J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
    Agostinelli C; Piccaluga PP; Went P; Rossi M; Gazzola A; Righi S; Sista T; Campidelli C; Zinzani PL; Falini B; Pileri SA
    J Clin Pathol; 2008 Nov; 61(11):1160-7. PubMed ID: 18755717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.
    Lone W; Alkhiniji A; Manikkam Umakanthan J; Iqbal J
    Curr Hematol Malig Rep; 2018 Aug; 13(4):318-328. PubMed ID: 29951889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis in PTCL-NOS with CADM1 expression.
    Kato T; Miyoshi H; Kobayashi S; Yoshida N; Imaizumi Y; Seto M; Uchimaru K; Miyazaki Y; Ohshima K
    Virchows Arch; 2017 Nov; 471(5):659-666. PubMed ID: 28940014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
    Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
    Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.